How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials

Daniele Santini, Antonio Galvano, Francesco Pantano, Lorena Incorvaia, Sergio Rizzo, B. Vincenzi, L. Castellana, Giovanna Giuliana, Fiorella Guadagni, Francesca Toia, Giuseppe Tonini, Antonio Russo, Giuseppe Badalamenti, Viviana Bazan

Research output: Contribution to journalReview articlepeer-review

Fingerprint Dive into the research topics of 'How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials'. Together they form a unique fingerprint.

Medicine & Life Sciences